Cholinesterase inhibitors and atypical antipsychotics may help manage dementia and psychosis in Parkinson's disease

被引：0
|
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 2007年 / 23卷 / 3期
关键词：
D O I：
10.2165/00042310-200723030-00003
中图分类号：
学科分类号：
摘要：
Patients with Parkinson's disease commonly experience symptoms of dementia and psychosis. Cholinesterase inhibitors modestly improve cognitive function, as well as psychotic symptoms, generally without adversely affecting motor function. Although studies are limited, atypical antipsychotics may help control psychotic symptoms, with minimal deleterious effects on motor function and cognition. © 2007 Adis Data Information BV. All rights reserved.
引用
收藏
页码：7 / 10
页数：3
相关论文
共 50 条
  • [11] Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
    Friedman, JH
    Factor, SA
    MOVEMENT DISORDERS, 2000, 15 (02) : 201 - 211
  • [12] Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series
    Sobow, Tomasz
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2007, 41 (03) : 276 - 279
  • [13] Agitation and psychosis during cholinesterase inhibitors (CEI) therapy in patients affected by Parkinson's disease and dementia (PDD)
    Thomas, A
    D'Andreamatteo, G
    Iacono, D
    Luciano, AL
    Di Rollo, A
    Onofrj, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S126 - S126
  • [14] Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia
    Ceravolo, R.
    Volterrani, D.
    Frosini, D.
    Bernardini, S.
    Rossi, C.
    Logi, C.
    Manca, G.
    Kiferle, L.
    Mariani, G.
    Murri, L.
    Bonuccelli, U.
    JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (11) : 1787 - 1790
  • [15] Comparative efficacy of cholinesterase inhibitors in dementia associated with Parkinson's disease
    Vasile, D.
    Vasiliu, O.
    Mangalagiu, A. G.
    Blandu, M.
    Nanca, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 174 - 174
  • [16] Comparative efficacy of cholinesterase inhibitors in dementia associated with Parkinson's disease
    Vasile, D.
    Vasiliu, O.
    Vasile, M. L.
    Terpan, M.
    Grigorescu, G.
    Bogdan, V.
    Mangalagiu, A.
    Petrescu, M. B.
    Ojog, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S553 - S554
  • [17] Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies
    Aarsland, D
    Mosimann, UP
    McKeith, IG
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2004, 17 (03) : 164 - 171
  • [18] Brain perfusion effects of cholinesterase inhibitors in Parkinson’s disease with dementia
    R. Ceravolo
    D. Volterrani
    D. Frosini
    S. Bernardini
    C. Rossi
    C. Logi
    G. Manca
    L. Kiferle
    G. Mariani
    L. Murri
    U. Bonuccelli
    Journal of Neural Transmission, 2006, 113 : 1787 - 1790
  • [19] Atypical antipsychotics for Parkinson's disease psychosis: a systematic review and meta-analysis
    Zhang, Han
    Wang, Limin
    Fan, Yafei
    Yang, Lianhong
    Wen, Xiaojun
    Liu, Yunyun
    Liu, Zhonglin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 2137 - 2149
  • [20] Acceptability of Atypical Antipsychotics in Treating Parkinson's Disease Psychosis: A Systematic Literature Review
    Yunusa, I.
    Rashid, N.
    Seyedin, R.
    Mahadik, B.
    Rajagopalan, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S93 - S93
12345